Glenmark pharmaceuticals share price target

Glenmark Pharmaceuticals Ltd. share price forecast The 16 reports from 8 analysts offering long term price targets for Glenmark Pharmaceuticals Ltd. have an average target of 408.88. The consensus estimate represents an upside of 85.52% from the last price of 220.40. GLENMARK | Complete Glenmark Pharmaceuticals Ltd. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. price target $240 Share, Status GLENMARK PHARMACEUTICALS LTD. (BSE: 532296) As on 28th Aug 2019 532296 Share Price closed @ 378.30 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 584.93 & Strong Sell for SHORT-TERM with Stoploss of 437.11 we also expect STOCK to react on Following IMPORTANT LEVELS.

7 Feb 2020 with a target price of Rs 304.0 . The current price of Glenmark Pharmaceuticals Ltd. is Rs 318.65 Time period given by the analyst is Intra Day  GLENMARK PHARMA: Get the latest GLENMARK PHARMA Share price and stock price updates, live NSE/BSE share price, share market reports, financial  Glenmark Pharmaceuticals Ltd Share Price- Get Glenmark Pharmaceuticals Ltd Stock/Share prices. Check Glenmark Pharmaceuticals Ltd's Live BSE/NSE  Glenmark Pharmaceuticals Ltd. Share Price Target and Information. Get complete details on Glenmark Pharmaceuticals Ltd. share price data, company profile  2 Dec 2019 In the short-term, the stock may try to bounce back. The long-term outlook for the Glenmark Pharmaceuticals (Rs 337.30) stock will remain negative as long as With a trailing stop loss, traders could aim for a target of ₹361.

How can I know the target price of shares or stocks? Glenmark Pharmaceuticals delivered a disastrous set of numbers in Q4 and resulted in the stock plunging 

Glenmark Pharmaceuticals GLENMARK share price forecast & targets for short-term is a downtrend, and nearest possible share price target is 206.4 The share price is currently trading at 217.80 However, if the trend reverses from this point, then a possible future share price target could be 278 Glenmark Pharmaceuticals Ltd. share price forecast The 16 reports from 8 analysts offering long term price targets for Glenmark Pharmaceuticals Ltd. have an average target of 408.88. The consensus estimate represents an upside of 85.52% from the last price of 220.40. GLENMARK | Complete Glenmark Pharmaceuticals Ltd. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. price target $240 Share, Status GLENMARK PHARMACEUTICALS LTD. (BSE: 532296) As on 28th Aug 2019 532296 Share Price closed @ 378.30 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 584.93 & Strong Sell for SHORT-TERM with Stoploss of 437.11 we also expect STOCK to react on Following IMPORTANT LEVELS.

1y Target Est 663.61 Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate.

1981 - The Company launced Candid-B Cream, a topical anti-fungal steroid combination to target the hitherto untapped market. 1985 - Candid Mouth Paint was  Glenmark Pharma Share Price, Stock Analysis of Glenmark Pharma, Future Prospects, experts view on buy/sell/hold Glenmark Pharmaceuticals Ltd. shares. Stock Tips for Glenmark Pharmaceuticals Limited. Stock Tips, Stock Trigger Price, Stop Loss, Stock Target 1, Stock Target 2. Buy Above, 230.72 

Shubham Aggarwal of Quantsapp Advisory has a sell call on Glenmark Pharmaceuticals Ltd. with a target price of Rs 304.0 . The current price of Glenmark Pharmaceuticals Ltd. is Rs 318.65 Time period given by the analyst is Intra Day when Glenmark Pharmaceuticals Ltd. price can reach defined target. .

GLENMARK PHARMACEUTICALS LTD. (BSE: 532296) As on 28th Aug 2019 532296 Share Price closed @ 378.30 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 584.93 & Strong Sell for SHORT-TERM with Stoploss of 437.11 we also expect STOCK to react on Following IMPORTANT LEVELS. Share market update: BSE Midcap index down; Glenmark Pharma plunges 21% - 5 day(s) ago GLENMARK PHARMA Surges by 12%; BSE HEALTHCARE Index Down 0.3% - 1 day(s) ago Glenmark Q3 net profit rises 64% to Rs 190.83 cr; to raise $400 mn - 14 Feb 2020 Shubham Aggarwal of Quantsapp Advisory has a sell call on Glenmark Pharmaceuticals Ltd. with a target price of Rs 304.0 . The current price of Glenmark Pharmaceuticals Ltd. is Rs 318.65 Time period given by the analyst is Intra Day when Glenmark Pharmaceuticals Ltd. price can reach defined target. . For the year ending June 2019 Glenmark Pharma has declared an equity dividend of 200.00% amounting to Rs 2 per share. At the current share price of Rs 299.20 this results in a dividend yield of 0.67%. GLENMARK | Complete Glenmark Pharmaceuticals Ltd. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. price target $240 Share, Status GLENMARK PHARMACEUTICALS LTD. (BSE: 532296) As on 28th Aug 2019 532296 Share Price closed @ 378.30 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 584.93 & Strong Sell for SHORT-TERM with Stoploss of 437.11 we also expect STOCK to react on Following IMPORTANT LEVELS.

GLENMARK Share Price - Glenmark Pharmaceuticals Limited NSE INDIA Technical Analysis, Target, Important Levels, Latest News, Interactive Charts.

Price (INR) 299.85 Today's Change 11.30 / 3.92% Shares traded 1.93m 1 Year change -49.92% Data delayed at least 15 minutes, as of Oct 18 2019 11:27 BST. You must be a registered user to save alerts. Please sign in or register. What is the Glenmark Pharmaceuticals stock price / share price today? The Glenmark Pharmaceuticals stock price is 209.450 INR today. Will Glenmark Pharmaceuticals Ltd stock price drop / fall? Get Live BSE/ NSE share price of Glenmark Pharma. View Glenmark Pharma historical charts, stock market reports, financial report, volume, market performance & latest news on NDTV Profit. Share market update: BSE Midcap index down; Glenmark Pharma plunges 21% - 5 day(s) ago GLENMARK PHARMA Surges by 12%; BSE HEALTHCARE Index Down 0.3% - 1 day(s) ago Glenmark Q3 net profit rises 64% to Rs 190.83 cr; to raise $400 mn - 14 Feb 2020 Glenmark Pharma share price jumped over 22 percent on November 18 after global research firm CLSA had upgraded the stocks to buy from sell and raised target to Rs 410 from Rs 350 per share.

Shubham Aggarwal of Quantsapp Advisory has a sell call on Glenmark Pharmaceuticals Ltd. with a target price of Rs 304.0 . The current price of Glenmark Pharmaceuticals Ltd. is Rs 318.65 Time period given by the analyst is Intra Day when Glenmark Pharmaceuticals Ltd. price can reach defined target. . For the year ending June 2019 Glenmark Pharma has declared an equity dividend of 200.00% amounting to Rs 2 per share. At the current share price of Rs 299.20 this results in a dividend yield of 0.67%. GLENMARK | Complete Glenmark Pharmaceuticals Ltd. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. price target $240 Share, Status GLENMARK PHARMACEUTICALS LTD. (BSE: 532296) As on 28th Aug 2019 532296 Share Price closed @ 378.30 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 584.93 & Strong Sell for SHORT-TERM with Stoploss of 437.11 we also expect STOCK to react on Following IMPORTANT LEVELS. Price (INR) 299.85 Today's Change 11.30 / 3.92% Shares traded 1.93m 1 Year change -49.92% Data delayed at least 15 minutes, as of Oct 18 2019 11:27 BST. You must be a registered user to save alerts. Please sign in or register.